UTHR NASDAQ
United Therapeutics Corporation
1W: +6.7%
1M: +21.8%
3M: +12.7%
YTD: +19.0%
1Y: +41.2%
3Y: +162.2%
5Y: +217.2%
$591.20
-1.64 (-0.28%)
Weekly Expected Move ±8.0%
$494
$541
$588
$634
$681
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' 16.42.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
-0.90
Bearish
0 bullish
0 neutral
1 bearish
Articles (24h)
1
Hourly Sentiment (24h)
-0.45
Bearish
0 bullish
1 neutral
1 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (100)
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares of Company Stock
Evergreen Capital Management LLC Sells 1,013 Shares of United Therapeutics Corporation $UTHR
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares of Company Stock
United Therapeutics (NASDAQ:UTHR) CEO Sells $5,129,905.00 in Stock
United Therapeutics (NASDAQ:UTHR) Stock: Insider Paul Mahon Sells 8,300 Shares
2,241 United Therapeutics Corporation $UTHR Shares Sold by First Citizens Bank & Trust Co.
Biotech2k Maps Insmed Incorporated (NASDAQ: INSM) TPIP Patent Path
LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label
Liquidia adds over 30% on United Thera. settlement; BTIG upgrades
SGIOY or UTHR: Which Is the Better Value Stock Right Now?
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Biggest stock movers Wednesday: DELL, LQDA, ENVX and more
Liquidia rockets 42% as $380.7M deal ends United Therapeutics legal battle
United Therapeutics (NASDAQ:UTHR) CEO Sells $5,215,025.00 in Stock
United Therapeutics Corporation (NASDAQ:UTHR) Stock Has Average Target Price of $627.31
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Top 10 Q3 insider stock sellers led by Nvidia’s Stevens, Jeff Bezos
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares of Stock
United Therapeutics (NASDAQ:UTHR) Stock: Insider Martine Rothblatt Sells 9,500 Shares
Liquidia extends losses as Wells Fargo adds to downgrades on legal setback
Liquidia Stock Plunges 57% on UTHR Patent Litigation Setback
Liquidia cut to Neutral at BTIG after patent win for United Therapeutics
UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13%
United Therapeutics (UTHR) Moves 12.6% Higher: Will This Strength Last?
United Therapeutics jumps 13% on court ruling
Liquidia plunges amid court ruling in United Therapeutics patent fight
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares of Company Stock
United Therapeutics (NASDAQ:UTHR) Stock: Insider Martine Rothblatt Sells 9,500 Shares
United Therapeutics, Sagimet drop after Goldman Sachs Sell ratings
Can LQDA's Yutrepia Outpace Intensifying PAH Competition?
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares of Stock
Nykredit A S Takes Position in United Therapeutics Corporation $UTHR
179,235 Shares in United Therapeutics Corporation $UTHR Bought by Bank of America Corp DE
Corient Private Wealth LP Reduces Stake in United Therapeutics Corporation $UTHR
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock
Ameritas Advisory Services LLC Sells 5,124 Shares of United Therapeutics Corporation $UTHR
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?
Why Is Altimmune (ALT) Up 14.2% Since Last Earnings Report?
Can a Potential Label Expansion of Yutrepia Boost LQDA's Portfolio?
United Therapeutics enters $477.6M accelerated share repurchase
Hsbc Holdings PLC Raises Stake in United Therapeutics Corporation $UTHR
United Therapeutics (UTHR) Down 8% Since Last Earnings Report: Can It Rebound?
FDA Accepts UTHR's sNDA for Tyvaso in Idiopathic Pulmonary Fibrosis
United Therapeutics (NASDAQ:UTHR) Trading Down 4.7% After Insider Selling
United Therapeutics bid to expand nebulized Tyvaso label gets FDA review
Ten healthcare stocks leading in year-over-year CapEx growth
Top Research Reports for Toyota Motor, CrowdStrike & Welltower
Can LQDA's Yutrepia Sustain Growth Amid Fierce PAH Competition?
Canada Pension Plan Investment Board Acquires New Position in United Therapeutics Corporation $UTHR
Freestone Grove Partners LP Acquires New Stake in United Therapeutics Corporation $UTHR
Corient Private Wealth LP Purchases New Holdings in United Therapeutics Corporation $UTHR
United Therapeutics highlights new data supporting two FDA filings
FDA Accepts United Therapeutics' NDA Filing for Ralinepag in PAH
Allient, Amkor Technology among those added by Fundstrat Granny Shots US Small- & Mid-Cap ETF in quarterly revision
Will LQDA's Differentiated PAH Approach Drive Growth?
Allworth Financial LP Invests $632,000 in United Therapeutics Corporation $UTHR
Can Merck's New Drugs Offer Growth Cushion Ahead of Keytruda LOE?
Can Yutrepia's Strong Growth Drive Liquidia's PAH Expansion?
BlackRock Inc. Makes New $2.87 Billion Investment in United Therapeutics Corporation $UTHR
UTHR Completes Phase III Tyvaso Study Enrollment for Expanded Label
LQDA Stock Down Post Q2 Earnings Release: What Should Investors Do Now?
Quant ratings on Renaissance Technologies top holdings: NVDA, META, INTC
HC Wainwright Issues Positive Forecast for UTHR Earnings
LQDA Q2 Earnings Top, Strong Yutrepia Sales Fuel Top-Line Growth
United Therapeutics (UTHR) Q2 2026 Earnings Call Transcript
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares
Assenagon Asset Management S.A. Purchases 37,355 Shares of United Therapeutics Corporation $UTHR
Atwood & Palmer Inc. Sells 957 Shares of United Therapeutics Corporation $UTHR
United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark
United Therapeutics (UTHR) Reports Q2 Earnings: What Key Metrics Have to Say
United Therapeutics (UTHR) Q2 Earnings Surpass Estimates
United Therapeutics Corporation Reports Second Quarter 2026 Financial Results - United Therapeutics Investor Relations
UTHR or SDZNY: Which Is the Better Value Stock Right Now?
Caerus Investment Advisors LLC Reduces Holdings in United Therapeutics Corporation $UTHR
Should You Invest in Liquidia Corporation Stock Ahead of Q2 Earnings?
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
United Therapeutics CEO Sells $5 Million of Shares. What Does This Mean for Investors?
Liquidia vs. United Therapeutics: Which PAH Stock Is the Better Buy Now?
Atika Capital Management LLC Invests $7.32 Million in United Therapeutics Corporation $UTHR
United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Q2 Release
Can LQDA's Differentiated PAH Strategy Drive Long-Term Growth?
California Public Employees Retirement System Grows Stock Holdings in United Therapeutics Corporation $UTHR
Bank of New York Mellon Corp Trims Holdings in United Therapeutics Corporation $UTHR
Allspring Global Investments Holdings LLC Grows Stock Holdings in United Therapeutics Corporation $UTHR
Can LQDA's Yutrepia Drive Growth in the Competitive PAH Market?
United Therapeutics Stock Rises 14% YTD: Here's What You Need to Know
Is United Therapeutics Corporation (UTHR) Stock a Long-Term Opportunity in Organ Transplant Innovation?
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
LQDA Stock Soars 129.7% YTD: Is There More Room for Growth?
UTHR Strengthens Regenerative Medicine Platform With Thymmune Deal
Can Yutrepia Maintain Momentum for LQDA Stock in 2026?
Bull of the Day: Neurocrine Biosciences (NBIX)
Retail traders rotate out of chip stocks into high-beta names
These 3 Stocks Lowered Their Share Counts Drastically in Q1
Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report?
SDZNY or UTHR: Which Is the Better Value Stock Right Now?
United Therapeutics Corporation (UTHR): Renaissance Technologies Likes This Biotech Stock
SA Asks: What are the most attractive biotech stocks right now?
Baidu, Brady And 3 Stocks To Watch Heading Into Monday